[The pharmacoeconomic efficacy of lurasidone in the treatment of schizophrenia].
Sergey ZyryanovI N DyakovA A JuperinD A EgorovaE S MosolovaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020)
Lurasidone is a more effective drug for treatment of schizophrenia from a pharmacoeconomic point of view in comparison with paliperidone and sertindole. With comparative efficacy with paliperidone and sertindole the use of lurasidone can significantly reduce the burden on budget of state programs of compensation for certain categories of citizens.